113 related articles for article (PubMed ID: 17156748)
21. Characterization of sugar recognition by the toxin complex produced by the Clostridium botulinum serotype C variant strain Yoichi.
Matsuo T; Miyata K; Inui K; Ito H; Horiuchi R; Suzuki T; Yoneyama T; Oguma K; Niwa K; Watanabe T; Ohyama T
FEMS Immunol Med Microbiol; 2011 Oct; 63(1):35-43. PubMed ID: 21635567
[TBL] [Abstract][Full Text] [Related]
22. Functional dissection of the Clostridium botulinum type B hemagglutinin complex: identification of the carbohydrate and E-cadherin binding sites.
Sugawara Y; Yutani M; Amatsu S; Matsumura T; Fujinaga Y
PLoS One; 2014; 9(10):e111170. PubMed ID: 25340348
[TBL] [Abstract][Full Text] [Related]
23. [Secretory immunoglobulin A in human milk and infants' feces at 1-4 months after delivery].
Wang F; Shi C
Zhonghua Fu Chan Ke Za Zhi; 1995 Oct; 30(10):588-90. PubMed ID: 8745502
[TBL] [Abstract][Full Text] [Related]
24. Inhibiting oral intoxication of botulinum neurotoxin A complex by carbohydrate receptor mimics.
Lee K; Lam KH; Kruel AM; Mahrhold S; Perry K; Cheng LW; Rummel A; Jin R
Toxicon; 2015 Dec; 107(Pt A):43-9. PubMed ID: 26272706
[TBL] [Abstract][Full Text] [Related]
25. Identification of the interaction region between hemagglutinin components of the botulinum toxin complex.
Suzuki T; Miyashita S; Hayashi S; Miyata K; Inui K; Kondo Y; Miyazaki S; Ohyama T; Niwa K; Watanabe T; Sagane Y
Int J Biol Macromol; 2014 Apr; 65():284-8. PubMed ID: 24472509
[TBL] [Abstract][Full Text] [Related]
26. Molecular properties of each subcomponent in Clostridium botulinum type B haemagglutinin complex.
Arimitsu H; Sakaguchi Y; Lee JC; Ochi S; Tsukamoto K; Yamamoto Y; Ma S; Tsuji T; Oguma K
Microb Pathog; 2008 Aug; 45(2):142-9. PubMed ID: 18550324
[TBL] [Abstract][Full Text] [Related]
27. Human milk containing specific secretory IgA inhibits binding of Giardia lamblia to nylon and glass surfaces.
Samra HK; Ganguly NK; Mahajan RC
J Diarrhoeal Dis Res; 1991 Jun; 9(2):100-3. PubMed ID: 1918831
[TBL] [Abstract][Full Text] [Related]
28. Multivalency effects of hemagglutinin component of type B botulinum neurotoxin complex on epithelial barrier disruption.
Amatsu S; Matsumura T; Yutani M; Fujinaga Y
Microbiol Immunol; 2018 Feb; 62(2):80-89. PubMed ID: 29266585
[TBL] [Abstract][Full Text] [Related]
29. Functional Analysis of Botulinum Hemagglutinin (HA).
Matsumura T; Fujinaga Y
Methods Mol Biol; 2020; 2132():191-200. PubMed ID: 32306328
[TBL] [Abstract][Full Text] [Related]
30. Hemagglutinin-33 of type A botulinum neurotoxin complex binds with synaptotagmin II.
Zhou Y; Foss S; Lindo P; Sarkar H; Singh BR
FEBS J; 2005 Jun; 272(11):2717-26. PubMed ID: 15943806
[TBL] [Abstract][Full Text] [Related]
31. Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes.
Fujinaga Y; Inoue K; Nomura T; Sasaki J; Marvaud JC; Popoff MR; Kozaki S; Oguma K
FEBS Lett; 2000 Feb; 467(2-3):179-83. PubMed ID: 10675534
[TBL] [Abstract][Full Text] [Related]
32. Reactivity of secretory IgA antibodies in breast milk from 107 Japanese mothers to 20 environmental antigens.
Takahashi T; Yoshida Y; Hatano S; Sugita-Konishi Y; Igimi S; Yajima M; Kojima T; Kanno T; Yonekubo A; Yajima T; Kuwata T
Biol Neonate; 2002; 82(4):238-42. PubMed ID: 12381931
[TBL] [Abstract][Full Text] [Related]
33. Botulinum Hemagglutinin: Critical Protein for Adhesion and Absorption of Neurotoxin Complex in Host Intestine.
Amatsu S; Fujinaga Y
Methods Mol Biol; 2020; 2132():183-190. PubMed ID: 32306327
[TBL] [Abstract][Full Text] [Related]
34. Short communication: Attempts to identify Clostridium botulinum toxin in milk from three experimentally intoxicated Holstein cows.
Moeller RB; Puschner B; Walker RL; Rocke TE; Smith SR; Cullor JS; Ardans AA
J Dairy Sci; 2009 Jun; 92(6):2529-33. PubMed ID: 19447984
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of monoclonal antibodies against haemagglutinin associated with Clostridium botulinum type C neurotoxin.
Mahmut N; Inoue K; Fujinaga Y; Hughes L; Arimitsu H; Sakaguchi Y; Ohtsuka A; Murakami T; Yokota K; Oguma K
J Med Microbiol; 2002 Apr; 51(4):286-294. PubMed ID: 11926732
[TBL] [Abstract][Full Text] [Related]
36. Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin.
Lee JC; Yokota K; Arimitsu H; Hwang HJ; Sakaguchi Y; Cui J; Takeshi K; Watanabe T; Ohyama T; Oguma K
Microbiology (Reading); 2005 Nov; 151(Pt 11):3739-3747. PubMed ID: 16272395
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of lipids tightly bound to secretory immunoglobulin A in antibody fractions from human breast milk possessing protein kinase activity.
Kit YY; Shipitsin MV; Semenov DV; Richter VA; Nevinsky GA
Biochemistry (Mosc); 1998 Jun; 63(6):719-24. PubMed ID: 9668213
[TBL] [Abstract][Full Text] [Related]
38. Botulism and vaccines for its prevention.
Smith LA
Vaccine; 2009 Nov; 27 Suppl 4():D33-9. PubMed ID: 19837283
[TBL] [Abstract][Full Text] [Related]
39. Characterization of haemagglutinin activity of Clostridium botulinum type C and D 16S toxins, and one subcomponent of haemagglutinin (HA1).
Inoue K; Fujinaga Y; Honke K; Yokota K; Ikeda T; Ohyama T; Takeshi K; Watanabe T; Inoue K; Oguma K
Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2533-2542. PubMed ID: 10517606
[TBL] [Abstract][Full Text] [Related]
40. Immunological properties of Hn-33 purified from type A Clostridium botulinum.
Sharma SK; Singh BR
J Nat Toxins; 2000 Nov; 9(4):357-62. PubMed ID: 11126514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
